TY  - ADVS
AU  - Tolaney,Sara M.
TI  - Immunotherapy: insights from advanced disease 
T2  - Periodic reports : advances in clinical interventions and research platforms,
PY  - 2019///
CY  - London
PB  - Henry Stewart Talks
KW  - Breast
KW  - Cancer
KW  - Immunological aspects
KW  - Treatment
KW  - Immunotherapy.
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - atezolizumab
KW  - Breast Neoplasms
KW  - drug therapy
KW  - immunology
KW  - Immunotherapy
KW  - Paclitaxel
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Checkpoint inhibitor therapy in breast cancer: focus on TNBC -- Limited activity for checkpoint inhibitor monotherapy in metastatic TNBC -- Atezolizumab + Nab-Paclitaxel: standard first line therapy for patients with metastatic PDL1 and -- Combination treatment with checkpoint inhibitor therapy in HR+ and HER2+ breast cancer -- Ongoing studies evaluating other strategies in breast cancer --  The future: combination of checkpoint inhibitors and chemotherapy; Access restricted to subscribers
UR  - https://hstalks.com/bs/4002/
UR  - https://hstalks.com/bs/p/1048/
ER  -